Package | us.nlm.vsac |
Type | ValueSet |
Id | Id |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1178.29/expansion |
Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.29 |
Version | 20220716 |
Status | active |
Date | 2022-07-16T01:02:12-04:00 |
Name | MRATherapy |
Title | MRA Therapy |
Experimental | False |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medications of mineralocorticoid receptor antagonists (MRA) therapy.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for mineralocorticoid receptor antagonists (MRA) therapy.),(Exclusion Criteria: Excludes concepts that represent non-prescribable, branded drugs, components or ingredients.) |
No resources found
CodeSystem | |
http://www.nlm.nih.gov/research/umls/rxnorm ![]() | RxNorm |
http://www.nlm.nih.gov/research/umls/rxnorm ![]() | RxNorm |
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1178.29",
"meta" : {
"versionId" : "11",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "AHA Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-01-24"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2022-07-16"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.29",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1178.29"
}
],
"version" : "20220716",
"name" : "MRATherapy",
"title" : "MRA Therapy",
"status" : "active",
"experimental" : false,
"date" : "2022-07-16T01:02:12-04:00",
"publisher" : "AHA Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of medications of mineralocorticoid receptor antagonists (MRA) therapy.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for mineralocorticoid receptor antagonists (MRA) therapy.),(Exclusion Criteria: Excludes concepts that represent non-prescribable, branded drugs, components or ingredients.)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "104232",
"display" : "spironolactone 5 MG/ML Oral Suspension"
},
{
"code" : "198222",
"display" : "spironolactone 100 MG Oral Tablet"
},
{
"code" : "198223",
"display" : "spironolactone 50 MG Oral Tablet"
},
{
"code" : "198224",
"display" : "hydrochlorothiazide 25 MG / spironolactone 25 MG Oral Tablet"
},
{
"code" : "198225",
"display" : "hydrochlorothiazide 50 MG / spironolactone 50 MG Oral Tablet"
},
{
"code" : "2562816",
"display" : "finerenone 10 MG Oral Tablet"
},
{
"code" : "2562824",
"display" : "finerenone 20 MG Oral Tablet"
},
{
"code" : "313096",
"display" : "spironolactone 25 MG Oral Tablet"
},
{
"code" : "351256",
"display" : "eplerenone 25 MG Oral Tablet"
},
{
"code" : "351257",
"display" : "eplerenone 50 MG Oral Tablet"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:49372c12-dceb-45b3-8903-646f9224edfa",
"timestamp" : "2024-12-10T07:28:40-05:00",
"total" : 10,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "104232",
"display" : "spironolactone 5 MG/ML Oral Suspension"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198222",
"display" : "spironolactone 100 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198223",
"display" : "spironolactone 50 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198224",
"display" : "hydrochlorothiazide 25 MG / spironolactone 25 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198225",
"display" : "hydrochlorothiazide 50 MG / spironolactone 50 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2562816",
"display" : "finerenone 10 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2562824",
"display" : "finerenone 20 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "313096",
"display" : "spironolactone 25 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "351256",
"display" : "eplerenone 25 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "351257",
"display" : "eplerenone 50 MG Oral Tablet"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.